Gemlapodect

N/A

Report date: 2024/05/30 11:45:31
NME

Base Information

Drug NameGemlapodect
Drug Alias NameNOE-105R O554965
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsChildhood-Onset Fluency DisorderStutteringTourette Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNoema Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesNoema Pharma AG
Inactive CompaniesN/A
Active IndicationsChildhood-Onset Fluency DisorderStutteringTourette Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A